| Series Introduction |
|
iii | |
| Preface |
|
ix | |
| Contributors |
|
xi | |
|
1. Oxidants and Antioxidants: Mechanism of Action and Regulation of Gene Expression by Bioflavonoids |
|
|
1 | (20) |
|
|
|
|
|
|
1 | (1) |
|
Introduction to Free Radicals and Antioxidants |
|
|
2 | (2) |
|
Mechanisms of Antioxidant Defense by Flavonoids |
|
|
4 | (3) |
|
Oxidative Stress and the Antioxidant Network |
|
|
7 | (2) |
|
Redox Regulation of Gene Expression |
|
|
9 | (3) |
|
Neuroactive Responses In Vivo to Ginkgo Biloba EGb 761 |
|
|
12 | (9) |
|
2. Transcriptional Regulation of Cellular Antioxidant Defense Mechanisms |
|
|
21 | (20) |
|
|
|
|
Toxicological vs. Physiological Functions of ROS |
|
|
22 | (2) |
|
Adaptive Response to Oxidative Injuries |
|
|
24 | (1) |
|
Cellular Antioxidant Defenses |
|
|
25 | (2) |
|
Transcriptional Regulation of Cellular Antioxidant and Detoxifying Enzymes |
|
|
27 | (6) |
|
ARE as a Critical Component of Nrf2-Mediated Antioxidant Defense |
|
|
33 | (1) |
|
|
|
33 | (8) |
|
3. Redox Regulation of Inflammatory Tissue Damage by Thioredoxin |
|
|
41 | (20) |
|
Shugo Ueda, Hajime Nakamura, Takayuki Nakamura, and Junji Yodoi |
|
|
|
|
|
41 | (1) |
|
Introduction-Redox Control by Thioredoxin System |
|
|
42 | (2) |
|
|
|
44 | (1) |
|
TRX System and Modulation of |
|
|
|
|
|
45 | (2) |
|
|
|
47 | (1) |
|
|
|
48 | (1) |
|
|
|
49 | (1) |
|
Therapeutic Approach Using Recombinant Human TRX-Translational Research |
|
|
50 | (1) |
|
|
|
51 | (10) |
|
4. Regulation of NF-kB-Driven Inflammatory Genes by Phytoestrogens |
|
|
61 | (46) |
|
Wim Vanden Berghe, Nathalie Dijsselbloem, An De Naeyer, Linda Vermeulen, and Guy Haegeman |
|
|
|
|
|
61 | (2) |
|
|
|
63 | (5) |
|
|
|
68 | (5) |
|
Induction Mechanisms of NF-kB-Driven Gene Induction |
|
|
73 | (4) |
|
Negative Modulation of NF-kB-Driven Gene Induction by Phytoestrogens |
|
|
77 | (4) |
|
|
|
81 | (26) |
|
5. Nuclear Factor-kB as Target for Chemoprevention |
|
|
107 | (20) |
|
|
|
|
|
|
107 | (1) |
|
|
|
107 | (1) |
|
Carcinogenesis/Tumorigenesis |
|
|
108 | (1) |
|
Cigarette Smoke and Cancer |
|
|
109 | (2) |
|
Effect of Cigarette Smoke on Pulmonary Inflammation |
|
|
111 | (1) |
|
Oxidative Damage by Cigarette Smoke |
|
|
112 | (1) |
|
Composition of Cigarette Smoke |
|
|
112 | (1) |
|
|
|
113 | (1) |
|
Relevance of NF-kB to Cigarette Smoking |
|
|
114 | (1) |
|
Why NF-kB Is Important for Cancer? |
|
|
114 | (3) |
|
Chemopreventive Agents Inhibit NF-kB Activation |
|
|
117 | (1) |
|
|
|
118 | (9) |
|
6. Heme Oxygenase-1: An Emerging Major Cellular Defense Against Cigarette Smoke-Induced Oxidative Stress and Cytotoxicity |
|
|
127 | (18) |
|
|
|
|
|
|
127 | (1) |
|
|
|
128 | (2) |
|
HO-1 Is the Most Strongly Induced Antioxidant Gene in CS-Exposed Cells, In Vitro and In Vivo |
|
|
130 | (2) |
|
CS-Exposed Fibroblasts with Impaired HO-1 Inducibility Exhibit Increased Cytotoxicity |
|
|
132 | (1) |
|
Swiss 3T3 Cells with Compromised HO-1 Inducibility Undergo Apoptosis When Exposed to CS |
|
|
133 | (2) |
|
The CS-Dependent Apoptotic Signal Is Transduced by JNK and p38 MAPK Pathways |
|
|
135 | (1) |
|
Absence of HO-1 Expression Is Associated with Apoptosis Induction in CS-Exposed U937 Cells |
|
|
136 | (2) |
|
|
|
138 | (7) |
|
7. Biphasic Induction of HO-1 in Macrophages Treated with Lipopolysaccharide: Role of HO-1 Induction in Cell Survival from Oxidative Stress |
|
|
145 | (50) |
|
Klaokwan Srisook and Young-Nam Cha |
|
|
|
|
|
145 | (5) |
|
Protective Effect of NO Against Cytotoxicity of ROS Only in the Presence of GSH |
|
|
150 | (2) |
|
Oxidative Stress and Inductions of iNOS and HO-1 |
|
|
152 | (3) |
|
|
|
155 | (4) |
|
Co-operative Interaction Between iNOS and HO-1 |
|
|
159 | (7) |
|
LPS-Derived Depletion of GSH and Sequential Induction of iNOS and HO-1 |
|
|
166 | (13) |
|
|
|
179 | (16) |
|
8. The Role of Gα12 Proteins in the PKC and JNK-Dependent Induction of NOS by Thrombin |
|
|
195 | (14) |
|
Sang Geon Kim, So Yeon Choi, Min Kyung Cho, Keon Wook Kang, and Chang Ho Lee |
|
|
|
|
|
195 | (1) |
|
|
|
196 | (2) |
|
Induction of iNOS by Thrombin |
|
|
198 | (1) |
|
Activation of NF-kB Transcription Factor |
|
|
198 | (2) |
|
NOS Induction and NF-kB Activation by Ga12/13 |
|
|
200 | (1) |
|
PKC-Mediated NF-kB Activation Downstream of Gα12/13 |
|
|
200 | (2) |
|
The Role of MAP Kinases in iNOS Induction |
|
|
202 | (1) |
|
Coupling of Ga12/13 to JNK |
|
|
202 | (1) |
|
JNK-Dependent Degradation of Phosphorylated I-kBα |
|
|
203 | (1) |
|
|
|
204 | (5) |
|
9. Actions of 8-Hydroxyguanine in DNA |
|
|
209 | (12) |
|
Jin Won Hyun and Myung Hee Chung |
|
|
|
|
|
209 | (1) |
|
8-Hydroxyguanine (8-Oxoguanine; oh8Gua) and Its Repair Enzymes |
|
|
210 | (1) |
|
Model for 8-Hydroxyguanine Studies |
|
|
211 | (3) |
|
8-Hydroxyguanine in DNA and Apoptosis |
|
|
214 | (1) |
|
Radiation, OGG1, and 8-Hydroxyguanine |
|
|
215 | (1) |
|
|
|
216 | (5) |
| 10. Role of Oxidative Stress in Hypercholesterolemia-Induced Inflammation |
|
221 | (24) |
|
Karen Y. Stokes, Anitaben Tailor, and D. Neil Granger |
|
|
|
|
|
221 | (1) |
|
Oxidative Stress-Generating Systems in Hypercholesterolemia |
|
|
222 | (4) |
|
Oxidative Stress and Inflammatory Responses During Hypercholesterolemia |
|
|
226 | (7) |
|
Linkage Between Microvascular and Macrovascular Responses to Hypercholesterolemia |
|
|
233 | (1) |
|
Antioxidant Strategies in Hypercholesterolemia |
|
|
234 | (2) |
|
|
|
236 | (9) |
| 11. Oxidative Stress in Rheumatoid Arthritis |
|
245 | (26) |
|
|
|
|
|
|
245 | (2) |
|
|
|
247 | (1) |
|
Involvement of NF-kB in RA as a Primary Pathogenic Determinant |
|
|
248 | (2) |
|
|
|
250 | (1) |
|
Oxido-Reduction of Proteins as a Signal: Redox Regulation |
|
|
251 | (1) |
|
Signaling Cascade for NF-kB Activation |
|
|
251 | (6) |
|
Roles of Thioredoxin in RA Pathophysiology |
|
|
257 | (4) |
|
|
|
261 | (10) |
| 12. Roles of Carbon Monoxide and Nitric Oxide in Liver Damage |
|
271 | (20) |
|
Hun-Taeg Chung, Hyun-Ock Pae, Byung-Min Choi, and Soo-Cheon Chae |
|
|
|
|
|
271 | (1) |
|
Roles of NO in Liver Damage |
|
|
272 | (4) |
|
Roles of CO in Liver Damage |
|
|
276 | (4) |
|
Interaction Between CO and NO in the Liver |
|
|
280 | (2) |
|
|
|
282 | (9) |
| 13. Role of Oxidative Stress and Inflammatory Response in Smokers and Chronic Obstructive Pulmonary Disease |
|
291 | (78) |
|
|
|
|
|
|
291 | (1) |
|
|
|
292 | (2) |
|
Chronic Obstructive Pulmonary Disease |
|
|
294 | (1) |
|
|
|
294 | (4) |
|
Inhaled Oxidants and Cigarette Smoke |
|
|
298 | (2) |
|
Alterations in the Alveolar Space |
|
|
300 | (1) |
|
|
|
301 | (1) |
|
Reactive Oxygen and Reactive Nitrogen Species as Surrogate Markers in Plasma and Exhaled Breath Condensate |
|
|
302 | (7) |
|
Depletion of Antioxidants |
|
|
309 | (3) |
|
|
|
312 | (1) |
|
Other Auxiliary Antioxidants |
|
|
313 | (1) |
|
Consequences of Oxidant/Antioxidant Imbalance |
|
|
314 | (1) |
|
|
|
315 | (1) |
|
Remodeling of Extracellular Matrix |
|
|
316 | (1) |
|
|
|
317 | (1) |
|
|
|
317 | (1) |
|
Oxidative Stress and the Development of Airway Obstruction |
|
|
318 | (1) |
|
Inflammation and Gene Expression |
|
|
319 | (6) |
|
Antioxidant Protective Genes |
|
|
325 | (3) |
|
Chromatin Remodeling (Histone Acetylation and Deacetylation) and Glucocorticoid Inefficacy |
|
|
328 | (5) |
|
Inflammation and Adenoviral E1A |
|
|
333 | (1) |
|
Oxidative Stress and Susceptibility to COPD |
|
|
334 | (1) |
|
Antioxidant Therapeutic Interventions |
|
|
335 | (1) |
|
|
|
336 | (4) |
|
|
|
340 | (29) |
| 14. Association of Chronic Inflammation with Carcinogenesis: Implications of Anti-inflammatory Strategies for Cancer Prevention |
|
369 | (20) |
|
Marie Yeo, Sang Uk Han, Ki Taik Nam, Dae Young Kim, Sung Won Cho, and Ki-Baik Hahm |
|
|
|
|
|
369 | (1) |
|
|
|
370 | (1) |
|
Association of Chronic Inflammation and Cancer in Gastroenterology |
|
|
371 | (1) |
|
Role of Oxidative Stress in GI Carcinogenesis |
|
|
372 | (2) |
|
Procancer Microenvironment Formation by Chronic, Persistent Inflammation |
|
|
374 | (6) |
|
Anti-Inflammatory Treatment as Cancer Prevention Strategy |
|
|
380 | (9) |
| 15. Molecular Inflammation as an Underlying Mechanism of Aging: The Anti-inflammatory Action of Calorie Restriction |
|
389 | (34) |
|
Hae Young Chung, Kyung Jin Jung, and Byung Pal Yu |
|
|
|
|
|
389 | (3) |
|
Biological Generation Sites of Reactive Species |
|
|
392 | (1) |
|
Inflammation Caused by Oxidative Stress |
|
|
393 | (4) |
|
Status of NF-kB in Inflammation and Aging |
|
|
397 | (2) |
|
Regulation of NF-kB Activation by IKK/NIK and MAPK |
|
|
399 | (5) |
|
Bases for Molecular Inflammation in Aging |
|
|
404 | (1) |
|
Supporting Evidence for the Molecular Inflammation Hypothesis |
|
|
405 | (5) |
|
|
|
410 | (13) |
| 16. Oxidative Stress in Mitochondria: The Involvement in Neurodegenerative Diseases |
|
423 | (22) |
|
Makoto Naoi, Wakako Maruyama, Masayo Shamoto-Nagai, Yoji Kato, and Masashi Tanaka Abstract |
|
|
424 | (21) |
|
Oxidative Stress and Modified Protein as the Marker |
|
|
425 | (4) |
|
Mitochondrial Complex I Subunits Are Nitrated by ONOO- |
|
|
429 | (5) |
|
Proteasome: Its Role in Accumulation of Oxidized Proteins |
|
|
434 | (1) |
|
Mitochondrial Dysfunction Inhibits the Proteasome System by Oxidative Modification |
|
|
435 | (3) |
|
|
|
438 | (7) |
| 17. Implications of Inflammatory Stress in Alzheimer's Disease |
|
445 | (26) |
|
Jung-Hee Jang and Young-Joon Surh |
|
|
|
|
|
445 | (1) |
|
Elevated Inflammatory Responses in AD |
|
|
446 | (3) |
|
Anti-inflammatory Therapy for AD |
|
|
449 | (1) |
|
Roles of COX-2 and Nitrosative Stress in Neuronal Cell Death |
|
|
450 | (4) |
|
Cross-Talk Between iNOS and COX Pathways in Inflammation |
|
|
454 | (2) |
|
Transcription Factors and Upstream Intracellular Signaling Molecules in Αβ-Induced Inflammation |
|
|
456 | (5) |
|
Conclusion and Future Directions |
|
|
461 | (10) |
| 18. Biomarkers for Evaluating Antioxidant Effects |
|
471 | (30) |
|
Robin van den Berg, Henk van den Berg, Guido R.M.M. Haenen, and Aalt Bast |
|
|
|
Free Radicals and Antioxidants: Need or Threat? |
|
|
471 | (4) |
|
How to Assess/Quantify Health Benefits From Antioxidants in Humans |
|
|
475 | (6) |
|
Methodologies of Markers for Evaluating Antioxidant Protection and Oxidative Damage |
|
|
481 | (6) |
|
Methods of Assessing Oxidative Damage |
|
|
487 | (14) |
| 19. Antioxidant and Neuroprotective Potentials |
|
501 | (24) |
|
Muhammad Soobrattee, Theeshan Bahorun, and Okezie I. Aruoma |
|
|
|
RNS/ROS and Oxidative Stress |
|
|
501 | (1) |
|
Neurodegenerative Disorders |
|
|
502 | (1) |
|
|
|
503 | (3) |
|
Antioxidants as Prophylactic Agents in the Management of AD |
|
|
506 | (19) |
| 20. Resveratrol-A Unique Polyphenolic Antioxidant Present in Grape Skins and Red Wine-Is a Preventive Medicine Against a Variety of Degenerative Diseases |
|
525 | (24) |
|
Dipak K. Das and Nilanjana Maulik |
|
|
|
|
|
525 | (1) |
|
|
|
526 | (2) |
|
|
|
528 | (3) |
|
Preconditioning with Resveratrol |
|
|
531 | (8) |
|
|
|
539 | (10) |
| 21. Molecular Mechanisms of Prevention Against Allergic Rhinitis by Aller-7, A Novel Polyherbal Formulation |
|
549 | (38) |
|
Debasis Bagchi, Amit Agarwal, Vinod S. Saxena, and Manashi Bagchi |
|
|
|
|
|
549 | (1) |
|
|
|
550 | (5) |
|
|
|
555 | (6) |
|
Pharmacological Activity Studies |
|
|
561 | (16) |
|
|
|
577 | (5) |
|
|
|
582 | (5) |
| 22. Antioxidant Character of Selenium and Its Survival Signals by Activation of PI3-K/Akt Pathways |
|
587 | (22) |
|
Sang-Oh Yoon, Jong-Min Park, and An-Sik Chung |
|
|
|
|
|
587 | (1) |
|
Selenium Deficiency and Glutathione Peroxidase Activity |
|
|
588 | (2) |
|
Selenium Increases Cell Proliferation and Blocks Apoptosis Induced by H2O2 |
|
|
590 | (1) |
|
Selenite Inhibits H2O2-Induced Apoptosis via the Inhibition of ASK1 Activity and Activation of PI3-K-Dependent Akt Activity |
|
|
591 | (4) |
|
Selenium Increases Glucose Uptake, ATP Generation, Mitochondrial Membrane Potential, and BCL-2 Expression but Decreases Caspase Activity |
|
|
595 | (5) |
|
|
|
600 | (9) |
| 23. Neuroprotection by Rasagiline and Related Propargylamines Is Mediated by Suppression of Mitochondrial Death Signal and Induction of Antiapoptotic Genes |
|
609 | (22) |
|
Wakako Maruyama, Yukihiro Akao, Makoto Naoi, and Atsumi Nitta |
|
|
|
|
|
610 | (1) |
|
Neuroprotection by Propargylamines: Intracellular Mechanism |
|
|
611 | (2) |
|
Induction of Neuroprotective Protein |
|
|
613 | (9) |
|
|
|
622 | (9) |
| Index |
|
631 | |